Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model.

PLoS Pathog · 2021 · PMC8376007 · PMID 34370799

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

For example, the virus titer differences (Fig 1) on day 5 are barely significant.

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.